Q3 2025 Holdings
Filed 2025-11-14 | 82 holdings | $162.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Contineum Therapeutics(CTNM) | CL A | 21217B100 | $9.4M | 800,787 | 5.8% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $7.2M | 9,376 | 4.4% |
| Structure Therapeutics(GPCR) | SP ADR | 86366E106 | $6.2M | 221,872 | 3.8% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $6.0M | 194,485 | 3.7% |
| Shoulder Innovations(SI) | COMMON STOCK | 82537J108 | $5.4M | 430,282 | 3.3% |
| Arcus Biosciences(RCUS) | COM | 03969F109 | $5.0M | 368,070 | 3.1% |
| Immatics NV(IMTX) | SHS | N44445109 | $4.8M | 560,494 | 2.9% |
| Unitedhealth GRP Inc(UNH) | COM | 91324P102 | $4.7M | 13,545 | 2.9% |
| Bicara Therapeutics(BCAX) | COM | 055477103 | $4.2M | 266,495 | 2.6% |
| Oric Pharmaceuticals(ORIC) | COM | 68622P109 | $3.9M | 328,655 | 2.4% |
| Solid Biosciences(SLDB) | COM NEW | 83422E204 | $3.9M | 633,052 | 2.4% |
| Kura Oncology(KURA) | COM | 50127T109 | $3.5M | 395,872 | 2.2% |
| Ventyx Biosciences(VTYX) | COM | 92332V107 | $3.4M | 1,107,267 | 2.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.4M | 14,800 | 2.1% |
| MBX Biosciences Inc(MBX) | COM | 55287L101 | $3.4M | 194,898 | 2.1% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $3.4M | 34,000 | 2.1% |
| Zenas Biopharma(ZBIO) | COM | 98937L105 | $3.4M | 152,025 | 2.1% |
| Palvella Therapeutic(PVLA) | COM | 697947109 | $3.1M | 49,115 | 1.9% |
| Tectonic Therapeutic(TECX) | COM | 878972108 | $3.0M | 192,770 | 1.9% |
| Vertex Pharma(VRTX) | COM | 92532F100 | $3.0M | 7,715 | 1.9% |
| Amgen Inc(AMGN) | COM | 031162100 | $2.9M | 10,340 | 1.8% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $2.9M | 161,380 | 1.8% |
| Argenx SE SPN ADR(ARGX) | SP ADR | 04016X101 | $2.9M | 3,890 | 1.8% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $2.8M | 15,300 | 1.8% |
| Intuitive Surgic Inc(ISRG) | COM NEW | 46120E602 | $2.6M | 5,750 | 1.6% |
| Beone Medicines LTD(ONC) | SP ADR | 07725L102 | $2.5M | 7,201 | 1.5% |
| Abbott Labs(ABT) | COM | 002824100 | $2.3M | 17,198 | 1.4% |
| Regeneron Pharmctcls(REGN) | COM | 75886F107 | $2.2M | 3,968 | 1.4% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $2.2M | 19,550 | 1.3% |
| Boston Scientific(BSX) | COM | 101137107 | $2.2M | 22,126 | 1.3% |
| Danaher Corp(DHR) | COM | 235851102 | $2.1M | 10,575 | 1.3% |
| Pfizer Inc(PFE) | COM | 717081103 | $2.0M | 77,150 | 1.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.9M | 13,425 | 1.2% |
| Thermo Fisher Scientific(TMO) | COM | 883556102 | $1.9M | 3,900 | 1.2% |
| Uniqure N.V.(QURE) | SHS | N90064101 | $1.8M | 30,740 | 1.1% |
| Biontech SE(BNTX) | SP ADR | 09075V102 | $1.7M | 17,660 | 1.1% |
| Stryker Corp(SYK) | COM | 863667101 | $1.6M | 4,300 | 1.0% |
| Summit Therapeutics(SMMT) | COM | 86627T108 | $1.5M | 74,070 | 0.9% |
| Alnylam Pharmacuetcl(ALNY) | COM | 02043Q107 | $1.5M | 3,273 | 0.9% |
| Astrazeneca(AZN) | SP ADR | 046353108 | $1.4M | 18,750 | 0.9% |
| Dexcom Inc(DXCM) | COM | 252131107 | $1.4M | 20,700 | 0.9% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $1.4M | 16,400 | 0.9% |
| Biomarin Pharmac Inc(BMRN) | COM | 09061G101 | $1.4M | 25,030 | 0.8% |
| Rapport Therapeutics(RAPP) | COM | 75383L102 | $1.3M | 43,480 | 0.8% |
| Mineralys Therapeutics(MLYS) | COM | 603170101 | $1.3M | 33,885 | 0.8% |
| Syndax Pharmaceuticals(SNDX) | COM | 87164F105 | $1.2M | 79,430 | 0.8% |
| Edwards Lifescience(EW) | COM | 28176E108 | $1.2M | 15,000 | 0.7% |
| Tarsus Pharmaceutical(TARS) | COM | 87650L103 | $1.1M | 18,405 | 0.7% |
| Merus B V | COM | N5749R100 | $1.1M | 11,545 | 0.7% |
| Trevi Therapeutics(TRVI) | COM | 89532M101 | $969.4K | 105,950 | 0.6% |